By integrating insights from microbiology, immunology, and pathomorphology, we aim to elucidate how extracellular Hsp60 contributes to the transition from infection to malignancy, and to identify potential targets for therapeutic intervention and immune modulation in H. pylori-associated gastric diseases. This evidence concerns the gene HSPD1 and infection.